Please assess the completion status of the following clinical trial:

Trial Title: EvAluation of Clinical Effectiveness Of RoLenium Administered With Elpenhaler in Chronic Obstructive Pulmonary Disease (COPD) patientS in Daily Clinical Practice, in Greece

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: OTHER
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* patients selected for treatment with the inhaled combination of propionic Fluticasone and Salmeterol (500+50)mcg - Rolenium- administered with Elpenhaler device~* FEV1 \<50% predicted normal (pre-bronchodilator),~* a history of repeated exacerbations who have significant symptoms despite regular bronchodilator therapy treated in Hospital outpatient specialist ward settings, in the daily clinical practice~* have signed informed consent~* be compliant with study procedures~Exclusion Criteria:~* - patients not selected for treatment with the inhaled combination of propionic~* FEV1 \>50% predicted normal (pre-bronchodilator),~* no history of repeated exacerbations~* not signed informed consent~* will not be compliant with study procedures

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).